Characteristics and predictors of ICU-mortality in critically ill patients with hyperlactatemia requiring CRRT: A retrospective cohort study

Abstract

Background:

Hyperlactatemia is a common complication in critically ill patients with high morbidity and mortality. Hyperlactatemia patients who require continuous renal replacement therapy (CRRT) constitute a subgroup with increased mortality risk. The clinical significance of serum lactate in these patients was not well understood and clearance of lactate using CRRT shown no survival benefits. The aim of this study is to investigate the incidence and non-lactate risk factors for ICU mortality in hyperlactatemia patients who underwent CRRT.

Method:

Hyperlactatemia patients with a serum lactate level >2 μmol/L who underwent CRRT between January, 2014 and May, 2021 were retrospectively investigated. Demographic characteristics and clinical data were collected from the electronic medical record system. The primary endpoint was predictors for ICU mortality which were identified by using multivariate logistic regression analysis.

Results:

A total of 178 eligible patients were finally included with a mean age of 56.6 ± 17.9 years and a median APACHE II score of 18 (IQR (14–22)). The multivariate regression results showed that male gender (OR 0.55 (95%CI 0.27–1.12), p = 0.1), mechanical ventilation (OR 2.60 (95%CI 1.27–5.34), p = 0.008), history of hypertension (OR 2.40 (95%CI 1.12–5.14), p = 0.02), SOFA score (OR 1.16 (95%CI 1.05–1.28), p = 0.002), AST (OR 1.0005 (95%CI 0.99–1.001), p = 0.08), and PT (OR 1.08 (95%CI 0.99–1.17), p = 0.06) were independently associated with ICU mortality. After adjusting for age, illness severity (APACHE II score), and serum lactate level, the statistical significances of SOFA score (OR 1.16 (95%CI 1.04–1.29), p = 0.005), hypertension (OR 2.25 (95%CI 1.02–4.95), p = 0.04), and mechanical ventilation (OR 2.54 (95%CI 1.22–5.25), p = 0.01) were not affected. The overall ICU mortality was 58.4% (104/178).

Conclusion:

The hyperlactatemia patients who underwent CRRT were at increased ICU mortality. Gender, AST, PT, SOFA score, history of hypertension, and mechanical ventilation were independent predictors for ICU mortality. Future studies with prospectively design, large sample size, and subgroup analyses are warranted to validate these findings.

Keywords

Critical illness hyperlactatemia continuous renal replacement therapy risk factors mortality

Get full access to this article

View all access options for this article.

References

Haas

Lange

Saugel

, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med 2016; 42: 202–210.

Gattinoni

Vasques

Camporota

, et al. Understanding lactatemia in human sepsis. Potential impact for early management. Am J Respir Crit Care Med 2019; 200: 582–589.

Ferreruela

Raurich

Ayestarán

, et al. Hyperlactatemia in ICU patients: incidence, causes and associated mortality. J Crit Care 2017; 42: 200–205.

Gharipour

Razavi

Gharipour

, et al. The incidence and outcome of severe hyperlactatemia in critically ill patients. Intern Emerg Med 2021; 16: 115–123.

Jansen

van Bommel

Woodward

, et al. Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med 2009; 37: 2369–2374.

Khosravani

Shahpori

Stelfox

, et al. Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Crit Care 2009; 13: R90.

Jansen

van Bommel

Schoonderbeek

, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 752–761.

Nichol

Egi

Pettila

, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010; 14: R25.

Nichol

Bailey

Egi

, et al. Dynamic lactate indices as predictors of outcome in critically ill patients. Crit Care 2011; 15: R242.

10.

Rishu

Khan

Al-Dorzi

, et al. Even mild hyperlactatemia is associated with increased mortality in critically ill patients. Crit Care 2013; 17: R197.

11.

Creagh-Brown

De Silva

Ferrando-Vivas

, et al. Relationship between peak lactate and patient outcome following high-risk gastrointestinal surgery: influence of the nature of their surgery: elective versus emergency. Crit Care Med 2016; 44: 918–925.

12.

Vellinga

NAR

Boerma

Koopmans

, et al. Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis. Crit Care 2017; 21: 255.

13.

De Corte

Dhondt

Vanholder

, et al. Long-term outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a prospective cohort study. Crit Care 2016; 20: 256.

14.

Van De Ginste

Vanommeslaeghe

Hoste

EAJ

, et al. Patients with severe lactic acidosis in the intensive care unit: a retrospective study of contributing factors and impact of renal replacement therapy. Blood Purif 2022; 51: 577–583.

15.

De Corte

Vuylsteke

De Waele

, et al. Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy. J Crit Care 2014; 29: 650–655.

16.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191–2194.

17.

Bai

Zhang

, et al. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: a retrospective case-control study. Int J Artif Organs 2022; 45: 343–350.

18.

Wang

Huang

, et al. Risk factors and in-hospital mortality of postoperative hyperlactatemia in patients after acute type A aortic dissection surgery. BMC Cardiovasc Disord 2021; 21: 431.

19.

Singer

Deutschman

Seymour

, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801–810.

20.

Redant

Hussein

Mugisha

, et al. Differentiating hyperlactatemia type A from type B: how does the lactate/pyruvate ratio help? J Transl Int Med 2019; 7: 43–45.

21.

Slowinski

Morgera

Joannidis

, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care 2015; 19: 349.

22.

Knaus

Draper

Wagner

, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829.

23.

Vincent

Moreno

Takala

, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707–710.

24.

Vrieze

. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods 2012; 17: 228–243.

25.

Zhang

Kattan

. Drawing Nomograms with R: applications to categorical outcome and survival data. Ann Transl Med 2017; 5: 211.

26.

Griffin

Liu

Teixeira

. Critical care nephrology: core curriculum 2020. Am J Kidney Dis 2020; 75: 435–452.

27.

Lambden

Laterre

Levy

, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care 2019; 23: 374.

28.

Medina-Liabres

KRP

Jeong

, et al. Mortality predictors in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Kidney Res Clin Pract 2021; 40: 401–410.

29.

Rhee

Jang

Park

, et al. Short- and long-term mortality rates of elderly acute kidney injury patients who underwent continuous renal replacement therapy. PLoS One 2016; 11: e0167067.

30.

Kee

Kim

, et al. Factors associated with early mortality in critically ill patients following the initiation of continuous renal replacement therapy. J Clin Med 2018; 7: 334.

31.

Liu

Zhang

Yue

, et al. Risk factors for mortality in patients undergoing continuous renal replacement therapy after cardiac surgery. BMC Cardiovasc Disord 2021; 21: 509.

32.

Koyner

Murray

. Mechanical ventilation and the kidney. Blood Purif 2010; 29: 52–68.

33.

Kao

Yang

Chen

, et al. Factors associated with poor outcomes of continuous renal replacement therapy. PLoS One 2017; 12: e0177759.

34.

Haider

Larson

Franklin

, et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10–16.

35.

Hobson

Craven

Blank

. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int 2012; 32: 590–594.

36.

Faubel

. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis 2008; 15: 284–296.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.25 MB